Protein chemical characterization of Gc globulin (vitamin D-binding protein) isoforms; Gc-1f, Gc-1s and Gc-2

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 4, 2007, Pages 481-492

  Christiansen, Maja ^a   Jørgensen, Charlotte S ^a   Laursen, Inga ^a   Hirschberg, Daniel ^b   Højrup, Peter ^b   Houen, Gunnar ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Gc globulin; Glycosylation; Isoforms; Mass spectrometry; Vitamin D binding protein

Indexed keywords

UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN; VITAMIN D BINDING PROTEIN 1F; VITAMIN D BINDING PROTEIN 1S; VITAMIN D BINDING PROTEIN 2;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; DNA SEQUENCE; HUMAN; ION EXCHANGE CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION;

CHROMATOGRAPHY, ION EXCHANGE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; HUMANS; PROTEIN ISOFORMS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VITAMIN D-BINDING PROTEIN;

EID: 33947639017     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.01.005     Document Type: Article

References (87)

1. White P., and Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol. Metab. 11 (2000) 320-327
2. Ray R. Molecular recognition in vitamin D-binding protein. Proc. Soc. Exp. Biol. Med. 212 (1996) 305-312
3. Haddad J.G. Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J. Steroid Biochem. Mol. Biol. 53 (1995) 579-582
4. Lee W.M., and Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N. Engl. J. Med. 326 (1992) 1335-1341
5. Cooke N.E., and Haddad J.G. Vitamin D binding protein (Gc-globulin). Endocr. Rev. 10 (1989) 294-307
6. Cooke N.E., and David E.V. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J. Clin. Invest. 76 (1985) 2420-2424
7. Yang F., Brune J.L., Naylor S.L., Cupples R.L., Naberhaus K.H., and Bowman B.H. Human group-specific component (Gc) is a member of the albumin family. Proc. Natl. Acad. Sci. U.S. A. 82 (1985) 7994-7998
8. Yang F., Luna V.J., McAnelly R.D., Naberhaus K.H., Cupples R.L., and Bowman B.H. Evolutionary and structural relationships among the group-specific component, albumin and alpha-fetoprotein. Nucleic Acids Res. 13 (1985) 8007-8017
9. Schoentgen F., Metz-Boutigue M.H., Jolles J., Constans J., and Jolles P. Homology between the human vitamin D-binding protein (group specific component), alpha-fetoprotein and serum albumin. FEBS Lett. 185 (1985) 47-50
10. Schoentgen F., Metz-Boutigue M.H., Jolles J., Constans J., and Jolles P. Complete amino acid sequence of human vitamin D-binding protein (group-specific component): evidence of a three-fold internal homology as in serum albumin and alpha-fetoprotein. Biochim. Biophys. Acta 871 (1986) 189-198
11. Lichenstein H.S., Lyons D.E., Wurfel M.M., Johnson D.A., McGinley M.D., Leidli J.C., Trollinger D.B., Mayer J.P., Wright S.D., and Zukowski M.M. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J. Biol. Chem. 269 (1994) 18149-18154
12. Nishio H., and Dugaiczyk A. Complete structure of the human alpha-albumin gene, a new member of the serum albumin multigene family. Proc. Natl. Acad. Sci. U.S. A. 93 (1996) 7557-7561
13. Song Y.H., Naumova A.K., Liebhaber S.A., and Cooke N.E. Physical and meiotic mapping of the region of human chromosome 4q11-q13 encompassing the vitamin D binding protein DBP/Gc-globulin and albumin multigene cluster. Genome Res. 9 (1999) 581-587
14. Ray R., Bouillon R., Van Baelen H., and Holick M.F. Photoaffinity labeling of human serum vitamin D binding protein and chemical cleavages of the labeled protein: identification of an 11.5-kDa peptide containing the putative 25-hydroxyvitamin D3 binding site. Biochemistry 30 (1991) 7638-7642
15. Haddad J.G., Hu Y.Z., Kowalski M.A., Laramore C., Ray K., Robzyk P., and Cooke N.E. Identification of the sterol- and actin-binding domains of plasma vitamin D binding protein (Gc-globulin). Biochemistry 31 (1992) 7174-7181
16. Verboven C., Rabijns A., De Maeyer M., Van Baelen H., Bouillon R., and De Ranter C. A structural basis for the unique binding features of the human vitamin D-binding protein. Nat. Struct. Biol. 9 (2002) 131-136
17. Otterbein L.R., Cosio C., Graceffa P., and Dominguez R. Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8003-8008
18. Head J.F., Swamy N., and Ray R. Crystal structure of the complex between actin and human vitamin D-binding protein at 2.5 A resolution. Biochemistry 41 (2002) 9015-9020
19. Haddad J.G., Harper K.D., Guoth M., Pietra G.G., and Sanger J.W. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc. Natl. Acad. Sci. U.S. A. 87 (1990) 1381-1385
20. Harper K.D., McLeod J.F., Kowalski M.A., and Haddad J.G. Vitamin D binding protein sequesters monomeric actin in the circulation of the rat. J. Clin. Invest. 79 (1987) 1365-1370
21. Dueland S., Nenseter M.S., and Drevon C.A. Uptake and degradation of filamentous actin and vitamin D-binding protein in the rat. Biochem. J. 274 Pt. 1 (1991) 237-241
22. Goldschmidt-Clermont P.J., Lee W.M., and Galbraith R.M. Proportion of circulating Gc (vitamin D-binding protein) in complexed form: relation to clinical outcome in fulminant hepatic necrosis. Gastroenterology 94 (1988) 1454-1458
23. Janmey P.A., Stossel T.P., and Lind S.E. Sequential binding of actin monomers to plasma gelsolin and its inhibition by vitamin D-binding protein. Biochem. Biophys. Res. Commun. 136 (1986) 72-79
24. Janmey P.A., and Lind S.E. Capacity of human serum to depolymerize actin filaments. Blood 70 (1987) 524-530
25. Mc Leod J.F., Kowalski M.A., and Haddad Jr. J.G. Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin. J. Biol. Chem. 264 (1989) 1260-1267
26. Tang W.X., Bazaraa H.M., Magiera H., Cooke N.E., and Haddad J.G. Electrophoretic mobility shift assay identifies vitamin D binding protein (Gc-globulin) in human, rat, and mouse sera. Anal. Biochem. 237 (1996) 245-251
27. Coue M., Constans J., and Olomucki A. Effects of serum vitamin-D-binding protein on actin in the presence of plasma gelsolin. Eur. J. Biochem. 160 (1986) 273-277
28. Lind S.E., Smith D.B., Janmey P.A., and Stossel T.P. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J. Clin. Invest. 78 (1986) 736-742
29. Lee W.M., Emerson D.L., Werner P.A., Arnaud P., Goldschmidt-Clermont P., and Galbraith R.M. Decreased serum group-specific component protein levels and complexes with actin in fulminant hepatic necrosis. Hepatology 5 (1985) 271-275
30. Lee W.M., Emerson D.L., Young W.O., Goldschmidt-Clermont P.J., Jollow D.J., and Galbraith R.M. Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis. Hepatology 7 (1987) 825-830
31. Lee W.M., Reines D., Watt G.H., Cook J.A., Wise W.C., Halushka P.V., and Galbraith R.M. Alterations in Gc levels and complexing in septic shock. Circ. Shock 28 (1989) 249-255
32. Lee W.M., Galbraith R.M., Watt G.H., Hughes R.D., McIntire D.D., Hoffman B.J., and Williams R. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 21 (1995) 101-105
33. Schiodt F.V., Bondesen S., and Tygstrup N. Serial measurements of serum Gc-globulin in acetaminophen intoxication. Eur. J. Gastroenterol. Hepatol. 7 (1995) 635-640
34. Schiodt F.V., Bondesen S., Petersen I., Dalhoff K., Ott P., and Tygstrup N. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure. Hepatology 23 (1996) 713-718
35. Schiodt F.V., Ott P., Bondesen S., and Tygstrup N. Reduced serum Gc-globulin concentrations in patients with fulminant hepatic failure: association with multiple organ failure. Crit. Care Med. 25 (1997) 1366-1370
36. Dahl B., Schiodt F.V., Kiaer T., Ott P., Bondesen S., and Tygstrup N. Serum Gc-globulin in the early course of multiple trauma. Crit.Care Med. 26 (1998) 285-289
37. Dahl B., Schiodt F.V., Ott P., Wians F., Lee W.M., Balko J., and O'Keefe G.E. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit. Care Med. 31 (2003) 152-156
38. Wians Jr. F.H., Lin W., Brown L.P., Schiodt F.V., and Lee W.M. Immunonephelometric quantification of group-specific component protein in patients with acute liver failure. Liver Transpl. Surg. 3 (1997) 28-33
39. Young W.O., Goldschmidt-Clermont P.J., Emerson D.L., Lee W.M., Jollow D.J., and Galbraith R.M. Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein). J. Lab. Clin. Med. 110 (1987) 83-90
40. Perez H.D. Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: an explanation for its cochemotaxin activity. Inflammation 18 (1994) 215-220
41. Kew R.R., Fisher J.A., and Webster R.O. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for C5a. Transient conversion into an active co-chemotaxin by neutrophils. J. Immunol. 155 (1995) 5369-5374
42. Yamamoto N., and Naraparaju V.R. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats. Cell Immunol. 170 (1996) 161-167
43. Yamamoto N., and Homma S. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc. Natl. Acad. Sci. U.S. A. 88 (1991) 8539-8543
44. Yamamoto N., and Kumashiro R. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. J. Immunol. 151 (1993) 2794-2802
45. Nagasawa H., Sasaki H., Uto Y., Kubo S., and Hori H. Association of the macrophage activating factor (MAF) precursor activity with polymorphism in vitamin D-binding protein. Anticancer Res. 24 (2004) 3361-3366
46. Nagasawa H., Uto Y., Sasaki H., Okamura N., Murakami A., Kubo S., Kirk K.L., and Hori H. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res. 25 (2005) 3689-3695
47. Mohamad S.B., Nagasawa H., Uto Y., and Hori H. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities. Anticancer Res. 22 (2002) 4297-4300
48. Mohamad S.B., Hori H., Nagasawa H., Usui K., and Uto Y. Characterization of human Gc protein-derived macrophage activation factor (GcMAF) and its functional role in macrophage tumoricidal activity. Adv. Exp. Med. Biol. 510 (2003) 77-82
49. Mohamad S.B., Nagasawa H., Sasaki H., Uto Y., Nakagawa Y., Kawashima K., and Hori H. Gc protein-derived macrophage activating factor (GcMAF): isoelectric focusing pattern and tumoricidal activity. Anticancer Res. 23 (2003) 4451-4457
50. Koga Y., Naraparaju V.R., and Yamamoto N. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice. Proc. Soc. Exp. Biol. Med. 220 (1999) 20-26
51. Kanda S., Mochizuki Y., Miyata Y., Kanetake H., and Yamamoto N. Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis. J. Natl. Cancer Inst. 94 (2002) 1311-1319
52. Kisker O., Onizuka S., Becker C.M., Fannon M., Flynn E., D'Amato R., Zetter B., Folkman J., Ray R., Swamy N., and Pirie-Shepherd S. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia 5 (2003) 32-40
53. Viau M., Constans J., Debray H., and Montreuil J. Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein. Biochem. Biophys. Res. Commun. 117 (1983) 324-331
54. Bouillon R., Van Baelen H., and de Moor P. The measurement of the vitamin D-binding protein in human serum. J. Clin. Endocrinol. Metab. 45 (1977) 225-231
55. Barragry J.M., Corless D., Auton J., Carter N.D., Long R.G., Maxwell J.D., and Switala S. Plasma vitamin D-binding globulin in vitamin D deficiency, pregnancy and chronic liver disease. Clin. Chim. Acta 87 (1978) 359-365
56. Walsh P.G., and Haddad J.G. "Rocket" immunoelectrophoresis assay of vitamin D-binding protein (Gc globulin) in human serum. Clin. Chem. 28 (1982) 1781-1783
57. Bouillon R., Auwerx J., Dekeyser L., Fevery J., Lissens W., and de Moor P. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J. Clin. Endocrinol. Metab. 59 (1984) 86-89
58. Goldschmidt-Clermont P.J., Galbraith R.M., Emerson D.L., Werner P.A., Nel A.E., and Lee W.M. Accurate quantitation of native Gc in serum and estimation of endogenous Gc: G-actin complexes by rocket immunoelectrophoresis. Clin. Chim. Acta 148 (1985) 173-183
59. Ogata M., Nakasono I., Iwasaki M., Kubo S., and Suyama H. Comparative immunological and electrophoretic analysis of Gc protein in sera from various animals. Comp. Biochem. Physiol. B 90 (1988) 193-199
60. Jorgensen C.S., Christiansen M., Norgaard-Pedersen B., Ostergaard E., Schiodt F.V., Laursen I., and Houen G. Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum. Scand. J. Clin. Lab. Invest. 64 (2004) 157-166
61. Arndt R.E. Group specific component: isoelectric focusing subtyping and immunoblot detection. J. Forensic Sci. 34 (1989) 1318-1322
62. Van Baelen H., Bouillon R., and de Moor P. The heterogeneity of human Gc-globulin. J. Biol. Chem. 253 (1978) 6344-6345
63. Cleve H., Constans J., Berg S., Hoste B., Ishimoto G., Matsumoto H., Spees E.K., and Weber W. Gc revisited: six further Gc-phenotypes delineated by isoelectric focusing and by polyacrylamide gel electrophoresis. Hum. Genet. 57 (1981) 312-316
64. Cleve H., and Constans J. The mutants of the vitamin-D-binding protein: more than 120 variants of the GC/DBP system. Vox Sang. 54 (1988) 215-225
65. Coppenhaver D.H., Sollenne N.P., and Bowman B.H. Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component). Arch. Biochem. Biophys. 226 (1983) 218-223
66. Svasti J., Kurosky A., Bennett A., and Bowman B.H. Molecular basis for the three major forms of human serum vitamin D binding protein (group-specific component). Biochemistry 18 (1979) 1611-1617
67. Lizana J., and Olsson I. High resolution isoelectric focusing in a narrow pH interval for the phenotyping of vitamin D-binding protein (Gc-globulin). J. Clin. Chem. Clin. Biochem. 22 (1984) 545-549
68. Westwood S.A., and Werrett D.J. Group-specific component: a review of the isoelectric focusing methods and auxiliary methods available for the separation of its phenotypes. Forensic Sci. Int. 32 (1986) 135-150
69. Svasti J., and Bowman B.H. Human group-specific component. Changes in electrophoretic mobility resulting from vitamin D binding and from neuraminidase digestion. J. Biol. Chem. 253 (1978) 4188-4194
70. Braun A., Bichlmaier R., and Cleve H. Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Hum. Genet. 89 (1992) 401-406
71. Reynolds R.L., and Sensabaugh G.F. Adv. Forensic Haemog. (1991) 158-161
72. Jørgensen C.S., Christiansen M., Laursen I., Krogsøe L.B., Højrup P., Blou L., and Houen G. Large scale purification and characterisation of non-glycosylated Gc globulin (vitamin D-binding protein) from plasma fraction IV. Biotecnol. Appl. Biochem. 44 (2006) 35-44
73. Kistler P., and Nitschmann H. Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier. Vox Sang. 7 (1962) 414-424
74. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
75. Studier F.W. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J. Mol. Biol. 79 (1973) 237-248
76. Rist W., Mayer M.P., Andersen J.S., Roepstorff P., and Jorgensen T.J. Rapid desalting of protein samples for on-line microflow electrospray ionization mass spectrometry. Anal. Biochem. 342 (2005) 160-162
77. Gobom J., Nordhoff E., Mirgorodskaya E., Ekman R., and Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34 (1999) 105-116
78. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
79. Larsen M.R., Hojrup P., and Roepstorff P. Characterization of gel-separated glycoproteins using two-step proteolytic digestion combined with sequential microcolumns and mass spectrometry. Mol. Cell Proteomics. 4 (2005) 107-119
80. Larsen M.R., Cordwell S.J., and Roepstorff P. Graphite powder as an alternative or supplement to reversed-phase material for desalting and concentration of peptide mixtures prior to matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 2 (2002) 1277-1287
81. Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., and Roepstorff P. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome Res. 3 (2004) 556-566
82. Yu Y.Q., Gilar M., Kaska J., and Gebler J.C. A rapid sample preparation method for mass spectrometric characterization of N-linked glycans. Rapid Commun. Mass Spectrom. 19 (2005) 2331-2336
83. Yoshida T. Peptide separation by Hydrophilic-Interaction Chromatography: a review. J. Biochem. Biophys. Methods 60 (2004) 265-280
84. Rickard E.C., Strohl M.M., and Nielsen R.G. Correlation of electrophoretic mobilities from capillary electrophoresis with physicochemical properties of proteins and peptides. Anal. Biochem. 197 (1991) 197-207
85. Benis K.A., and Schneider G.B. The effects of vitamin D binding protein-macrophage activating factor and colony-stimulating factor-1 on hematopoietic cells in normal and osteopetrotic rats. Blood 88 (1996) 2898-2905
86. Swamy N., Ghosh S., Schneider G.B., and Ray R. Baculovirus-expressed vitamin B-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D3 does not influence this activity. J. Cell. Biochem. 81 (2001) 535-546
87. Datta H.K., Cook D.B., and Kanan R.M. Evidence for continuous basal generation of Gc-MAF; absence in infantile osteopetrosis and restoration after bone marrow transplant. Blood 93 (1999) 4026-4027